Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Forecast for the Chronic Pruritus Therapeutics Market from 2024 to 2025?
The market size for treatments of chronic pruritus has seen substantial growth in recent years. The market is projected to increase from $10.17 billion in 2024 to $10.94 billion in 2025, with a compound annual growth rate (CAGR) of 7.6%. The expansion during the historical period is due to factors such as an increased incidence of chronic pruritus, growing need for efficacious treatments, more regulatory approvals, an uptick in product clearances, and an escalation in the incidence of mergers, collaborations, and acquisitions among industry players.
What Is the Projected Market Size of the Chronic Pruritus Therapeutics Market?
In the ensuing years, the market size for chronic pruritus therapeutics is anticipated to witness robust expansion. The market prediction is a growth to $14.49 billion by 2029, with a compound annual growth rate (CAGR) of 7.3%. The forecasted growth period is linked to increased awareness, surge in atopic dermatitis cases, emphasis on personal medicine, higher occurrence of dermatological conditions, and expanding patient population. The forecast period is also expected to see major trends such as the introduction of pioneering medicines, creation of ground-breaking biologics and targeted therapies, technological enhancements, assimilation of cutting-edge drug delivery systems, partnerships between pharmaceutical organizations and research institutions, as well as the emergence of digital health technologies like telemedicine.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21147&type=smp
Who are the Major Competitors in the Chronic Pruritus Therapeutics Market Outlook?
Major companies operating in the chronic pruritus therapeutics market are Pfizer Incorporated, AbbVie Inc., Sanofi S.A., Novartis Aktiengesellschaft, GlaxoSmithKline plc, Toray Industries Inc., CSL Behring LLC, Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Ipsen S.A., Incyte Corporation, Cipla Limited, H. Lundbeck A/S, Sumitomo Pharma Co. Ltd., Mallinckrodt Pharmaceuticals plc, Kissei Pharmaceutical Co. Ltd., Asana BioSciences LLC, Vanda Pharmaceuticals Inc., Dermavant Sciences Inc., Galderma Laboratories L.P., Cara Therapeutics Inc., Avior Bio Inc., Trevi Therapeutics Inc.
What Is Fueling Growth in the Chronic Pruritus Therapeutics Market?
The growing incidence of atopic dermatitis is anticipated to fuel the growth of the chronic pruritus therapeutics market in the future. Atopic dermatitis (AD) is a long-term inflammatory skin disease characterized by symptoms including redness, dryness, and itchiness, typically impacting individuals who have a family history of allergies, hay fever, or asthma. The cause of increasing cases of atopic dermatitis can lay blame on factors like genetic predisposition, lifestyle changes, alterations in the environment, the hygiene hypothesis, overexposure to allergens, and imbalances in the skin microbiome. Chronic pruritus therapeutics are designed to ease the continuous itchiness associated with atopic dermatitis by focusing on inflammatory pathways, reducing skin inflammation and improving patient comfort. For example, the International Eczema Council, a nonprofit organization based in the US, estimated that in 2022, approximately 223 million people worldwide were suffering from atopic dermatitis (GBD 2022), which includes 43 million children between the ages of 1-4, highlighting the substantial incidence of this condition in early childhood. As such, the increasing occurrence of atopic dermatitis is cited as a key driver in the expansion of the chronic pruritus therapeutics market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=21147&type=smp
Which Chronic Pruritus Therapeutics Market Segments Are Growing the Fastest?
The chronic pruritus therapeutics market covered in this report is segmented –
1) By Product Type: Corticosteroid, Antihistamine, Local Anesthetic, Counterirritant, Immunosuppressant, Calcineurin Inhibitors, Other Product Types
2) By Disease Type: Atopic Dermatitis, Allergic Contact Dermatitis, Urticaria, Other Disease Types
3) By Distribution Channel: Hospital Pharmacies, Drug stores And Retail Pharmacies, Online Providers
Subsegments:
1) By Corticosteroid: Topical Corticosteroids, Oral Corticosteroids, Injectable Corticosteroids
2) By Antihistamine: First-Generation Antihistamines, Second-Generation Antihistamines
3) By Local Anesthetic: Topical Local Anesthetics, Injectable Local Anesthetics
4) By Counterirritant: Menthol-Based Counterirritants, Camphor-Based Counterirritants
5) By Immunosuppressant: Systemic Immunosuppressants, Topical Immunosuppressants
6) By Calcineurin Inhibitors: Tacrolimus-Based Therapy, Pimecrolimus-Based Therapy
7) By Other Product Types: Biologic Therapies, Emerging Novel Therapies
Which Industry Trends Are Shaping the Future of the Chronic Pruritus Therapeutics Market?
Leading corporations in the chronic pruritus therapeutics market are centering their efforts on the creation of novel formulations such as the intravenous (IV) injection to augment the effectiveness of treatments and provide quick relief to patients. The use of IV injection in pruritus treatment allows for antihistamines or corticosteroids to be directly injected into the bloodstream, swiftly relieving itching and reducing inflammation. An example of this is when Cara Therapeutics Inc., a US-based therapeutics manufacturer, announced in September 2023 that its partner, Maruishi Pharmaceutical Co. Ltd, a Japanese pharmaceutical company, gained approval from Japan’s Ministry of Health, Labour and Welfare for its Korsuva IV injection syringe. This treatment for pruritus in hemodialysis patients was approved following the positive outcome of a Phase 3 clinical trial led by Maruishi in partnership with Kissei Pharmaceutical Co., Ltd. The application demonstrated a considerable enhancement in itching scores in comparison to a placebo and was generally well-received by patients. According to the licensing agreement with Maruishi, Cara Therapeutics, the creator of Korsuva, will receive a milestone payment of $1.5 million following this approval.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/chronic-pruritus-therapeutics-global-market-report
Which Countries Are Leading the Chronic Pruritus Therapeutics Market?
North America was the largest region in the chronic pruritus therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic pruritus therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21147
This Report Delivers Insight On:
1. How big is the chronic pruritus therapeutics market, and how is it changing globally?
2. Who are the major companies in the chronic pruritus therapeutics market, and how are they performing?
3. What are the key opportunities and risks in the chronic pruritus therapeutics market right now?
4. Which products or customer segments are growing the most in the chronic pruritus therapeutics market?
5. What factors are helping or slowing down the growth of the chronic pruritus therapeutics market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model